FR2223014A1 - - Google Patents

Info

Publication number
FR2223014A1
FR2223014A1 FR7409975A FR7409975A FR2223014A1 FR 2223014 A1 FR2223014 A1 FR 2223014A1 FR 7409975 A FR7409975 A FR 7409975A FR 7409975 A FR7409975 A FR 7409975A FR 2223014 A1 FR2223014 A1 FR 2223014A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7409975A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of FR2223014A1 publication Critical patent/FR2223014A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J11/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0029Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
FR7409975A 1973-03-26 1974-03-22 Withdrawn FR2223014A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US344838A US3890356A (en) 1973-03-26 1973-03-26 7-Alkyl-{66 {hu 3,5{b -steroids

Publications (1)

Publication Number Publication Date
FR2223014A1 true FR2223014A1 (fr) 1974-10-25

Family

ID=23352273

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7409975A Withdrawn FR2223014A1 (fr) 1973-03-26 1974-03-22

Country Status (9)

Country Link
US (1) US3890356A (fr)
JP (1) JPS49126661A (fr)
AU (1) AU6558474A (fr)
BE (1) BE812836A (fr)
CA (1) CA1027929A (fr)
DE (1) DE2413559A1 (fr)
FR (1) FR2223014A1 (fr)
GB (1) GB1410294A (fr)
ZA (1) ZA74932B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US7704983B1 (en) 1992-03-02 2010-04-27 Eastern Virginia Medical School Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
US5516769A (en) * 1993-02-19 1996-05-14 The Medical College Of Hampton Roads Method of inhibiting fertilization
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3351639A (en) * 1963-03-20 1967-11-07 American Cyanamid Co 17-alkyl-20-keto substituted pregnenes, pregnadienes and methods of preparing the same
US3246022A (en) * 1964-06-04 1966-04-12 Searle & Co 3-aryl-17beta-oxy (androsta/estra)-3, 5-dienes
US3471531A (en) * 1966-04-07 1969-10-07 Herchel Smith Synthesis of gona-3,5-dienes
CH537373A (de) * 1966-10-28 1973-05-31 Ciba Geigy Ag Verfahren zur Herstellung neuer 7d-Methyl- 3,5--östradiene
US3553213A (en) * 1969-03-17 1971-01-05 American Home Prod 17-alpha-aminoalkynyl-3-chloro 19-norsteroidal 3,5-dienes

Also Published As

Publication number Publication date
ZA74932B (en) 1975-01-29
GB1410294A (en) 1975-10-15
DE2413559A1 (de) 1974-10-17
CA1027929A (fr) 1978-03-14
BE812836A (fr) 1974-07-15
AU6558474A (en) 1975-08-14
US3890356A (en) 1975-06-17
JPS49126661A (fr) 1974-12-04

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU465453B2 (fr)
AU465434B2 (fr)
AU471343B2 (fr)
AU450229B2 (fr)
FR2223014A1 (fr)
AR201229Q (fr)
AU472848B2 (fr)
AU466283B2 (fr)
AR199451A1 (fr)
AU447540B2 (fr)
AU461342B2 (fr)
AU471461B2 (fr)
AR195311A1 (fr)
AR200885A1 (fr)
AR193950A1 (fr)
AR195948A1 (fr)
AR200256A1 (fr)
AR210729A1 (fr)
AR197627A1 (fr)
AR201432A1 (fr)
AR196382A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse